Cancer diagnostics are becoming increasingly complex, Medline said in an April 17 news release. The company is expanding its laboratory device portfolio, which now includes more than 150,000 products.
“Medline lab specialists bring lab, supply chain and other stakeholders together to build a framework for driving greater savings, efficiencies, and overall value,” the release said.